RetinalGenix Technologies (RTGN) Preferred Shares (2020 - 2021)
RetinalGenix Technologies (RTGN) posted Preferred Shares of $300.0 for Q3 2021, little changed sequentially from $300.0 in Q4 2020.
RetinalGenix Technologies (RTGN) Preferred Shares (2020 - 2021) Analysis & Trends
RetinalGenix Technologies has reported Preferred Shares for 2 years, with the latest figure at $300.0 in Q3 2021.
- Quarterly Preferred Shares changed N/A year-over-year to $300.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $300.0 (changed N/A YoY) and the FY2020 annual result came in at $300.0, changed N/A from the prior year.
- Preferred Shares held at $300.0 in Q3 2021 per RTGN's latest filing, from $300.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $300.0 in Q4 2020 and troughed at $300.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 300.00 |
| Dec 31, 2020 | 300.00 |